3-{[(3S)-2-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]formamido}-4-cyclopropyl-N-({[(S)-(dimethylcarbamoyl)(phenyl)methyl]carbamoyl}methyl)-2-oxobutanamide

InChIKey	`SIORZSNWZVSXNL-UKRMLWEFSA-N`
Compound Name	3-{[(3S)-2-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]formamido}-4-cyclopropyl-N-({[(S)-(dimethylcarbamoyl)(phenyl)methyl]carbamoyl}methyl)-2-oxobutanamide
Canonical SMILES	`CN(C)C(=O)[C@@H](NC(=O)CNC(=O)C(=O)C(CC1CC1)NC(=O)[C@@H]1C2CCC(C2)N1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)c1ccccc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.49
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08246	ELANE	Homo sapiens	Human	PF00089	6.5	Ki	ChEMBL
A3EZJ3	NS3	Hepacivirus hominis	Pathogen	PF07652 PF22027 PF02907	8.0	Ki	ChEMBL
P27958		Hepatitis C virus genotype 1a (isolate H77)	Pathogen	PF07652 PF01543 PF01542 PF01539 PF01560 PF01538 PF01006 PF01001 PF01506 PF08300 PF08301 PF12941 PF22027 PF02907 PF00998	8.0	Ki	BindingDB